Skip to content

Neuraxis (NRXS) IPO deck

Neuraxis is a medical technology company focused on developing neuromodulation therapies to address chronic and debilitating conditions in children and adults.

This post is for subscribers only

Subscribe

Already have an account? Sign In

Latest